Related Experiment Video
Updated: Jun 25, 2026
A Familiarization Protocol Facilitates the Participation of Children with ASD in Electrophysiological Research
Published on: July 31, 2017
Parent-reported experiences of in-laboratory polysomnography in children with neurodevelopmental disorders: A
Ajay Kevat1,2, Dhruv Alwadhi2, Andrew Collaro1,2
1Department of Respiratory and Sleep Medicine, Queensland Children's Hospital, South Brisbane, QLD, Australia.
Insights
Parents reported that in-laboratory polysomnography (PSG) caused moderate worry in children with neurodevelopmental disorders (NDD), with many preferring at-home sleep tests. This highlights the need for more child-friendly diagnostic options.
Area of Science:
- Pediatric Sleep Medicine
- Neurodevelopmental Disorders
- Clinical Diagnostics
Background:
- In-laboratory polysomnography (PSG) is the standard for diagnosing pediatric sleep disorders.
- Children with neurodevelopmental disorders (NDD) often struggle with PSG tolerance.
- Parental experiences with PSG in NDD populations are underexplored.
Purpose of the Study:
- To assess parent-reported experiences of in-laboratory PSG for children with NDD.
- To identify factors linked to negative PSG experiences in this group.
- To gauge preferences for alternative sleep testing methods.
Main Methods:
- Cross-sectional multicenter study involving 143 children with NDD.
- Parents completed surveys on child/parent worry, tolerance, and overall PSG experience.
- Statistical analyses (ANOVA, Chi-squared, Kruskal-Wallis) identified associated factors.
Main Results:
- Parents reported moderate child worry during PSG.
- Autism spectrum/neuromuscular disorders correlated with higher worry and non-representative sleep.
- 57% of parents preferred in-home mat-based testing over in-laboratory PSG.
Conclusions:
- In-laboratory PSG in children with NDD is associated with child worry and concerns about sleep representativeness.
- Parental preference leans towards in-home sleep studies for improved patient experience.
- Findings suggest a need for more accessible and child-centered sleep diagnostic approaches.
Purpose:
In-laboratory polysomnography (PSG) is the gold standard test for diagnosing certain paediatric sleep conditions. Children with neurodevelopmental disorders (NDD) often have difficulty tolerating PSG, but parent and patient experiences of PSG for children with NDD have not been thoroughly explored. The study aim was to evaluate the parent-reported experience of in-laboratory PSG undertaken in children with NDD and to identify factors predictive of poorer experience.
Methods:
In this cross-sectional multicentre study, parents of 143 children with NDD who underwent in-laboratory PSG completed a customised survey to provide feedback on parent and child worry levels, subjective tolerance and overall experience of PSG, and hypothetical preference between in-laboratory PSG versus an in-home mat-based sleep test. ANOVA, Chi-squared and Kruskal-Wallis tests were used to determine participant factors associated with these outcomes.
Results:
On average, parents rated their child's worry level with respect to undergoing PSG as 'moderate,' but their own worry levels lower. Autism spectrum / neuromuscular disorder diagnoses were risk factors for both higher worry score and reporting that sleep during PSG was non-representative of usual sleep at home. Parental preference was for in-home (mat-based) testing, with 57% indicating a preference for this if it wereavailable vs. 7% preferring in-laboratory testing.
Conclusion:
Parent/carer reports regarding in-laboratory PSG experiences for their children with NDD suggest the test is associated with child worry and concerns that the sleep is not-representative of usual sleep at home. Consumer preference favours in-home sleep study testing over current in-laboratory diagnostic testing.
Clinical Trial Registration:
This study is part of a larger trial ACTRN12622001544763.
Related Concept Videos
02:07Blind Procedures
01:15REM Sleep Behavior Disorder
RBD is significantly associated with...